These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18045073)

  • 1. Recent approaches in chemoprevention of prostate cancer.
    Young CY
    Curr Cancer Drug Targets; 2007 Nov; 7(7):681-8. PubMed ID: 18045073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprevention of prostate cancer.
    Kucuk O
    Cancer Metastasis Rev; 2002; 21(2):111-24. PubMed ID: 12465750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carotenoids and prostate cancer risk.
    Young CY; Yuan HQ; He ML; Zhang JY
    Mini Rev Med Chem; 2008 May; 8(5):529-37. PubMed ID: 18473940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can we prevent prostate cancer? Rationale and current status of prostate cancer chemoprevention.
    Fujimoto N; Chang C; Nomura M; Matsumoto T
    Urol Int; 2005; 74(4):289-97. PubMed ID: 15897691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer chemoprevention by natural agents: Clinical evidence and potential implications.
    Chhabra G; Singh CK; Ndiaye MA; Fedorowicz S; Molot A; Ahmad N
    Cancer Lett; 2018 May; 422():9-18. PubMed ID: 29471004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention of prostate cancer: current status and future directions.
    Lieberman R
    Cancer Metastasis Rev; 2002; 21(3-4):297-309. PubMed ID: 12549768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer chemoprevention: Strategies for designing efficient clinical trials.
    Lieberman R
    Urology; 2001 Apr; 57(4 Suppl 1):224-9. PubMed ID: 11295633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer prevention: agent development strategies.
    Parnes HL; House MG; Tangrea JA
    Recent Results Cancer Res; 2014; 202():121-31. PubMed ID: 24531786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprevention of prostate cancer.
    Brand TC; Canby-Hagino ED; Pratap Kumar A; Ghosh R; Leach RJ; Thompson IM
    Hematol Oncol Clin North Am; 2006 Aug; 20(4):831-43. PubMed ID: 16861117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemoprevention of prostate cancer].
    Djavan B; Thompson I; Michel MS; Waldert M; Seitz C
    Urologe A; 2004 May; 43(5):557-61. PubMed ID: 15042290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemoprevention of prostate cancer].
    Xie LP; Qin J
    Zhonghua Nan Ke Xue; 2005 Apr; 11(4):243-6. PubMed ID: 15921250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoprevention in prostate cancer.
    Assikis V; Brawley OW
    Curr Probl Cancer; 2004; 28(4):218-30. PubMed ID: 15318324
    [No Abstract]   [Full Text] [Related]  

  • 13. Advances in prostate cancer chemoprevention: a translational perspective.
    Nambiar D; Singh RP
    Nutr Cancer; 2013; 65 Suppl 1():12-25. PubMed ID: 23682779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoprevention of prostate cancer.
    Rittmaster RS
    Acta Oncol; 2011 Jun; 50 Suppl 1():127-36. PubMed ID: 21604953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations.
    Lieberman R; Nelson WG; Sakr WA; Meyskens FL; Klein EA; Wilding G; Partin AW; Lee JJ; Lippman SM
    Urology; 2001 Apr; 57(4 Suppl 1):4-27. PubMed ID: 11295590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer chemoprevention: current status and future prospects.
    Gupta S
    Toxicol Appl Pharmacol; 2007 Nov; 224(3):369-76. PubMed ID: 17189645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidants for prostate cancer chemoprevention: challenges and opportunities.
    Thapa D; Ghosh R
    Biochem Pharmacol; 2012 May; 83(10):1319-30. PubMed ID: 22248733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of action of novel agents for prostate cancer chemoprevention.
    Singh RP; Agarwal R
    Endocr Relat Cancer; 2006 Sep; 13(3):751-78. PubMed ID: 16954429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target populations and strategies for chemoprevention trials of prostate cancer.
    Bostwick DG
    J Cell Biochem Suppl; 1994; 19():191-6. PubMed ID: 7823591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural Compounds in Prostate Cancer Prevention and Treatment: Mechanisms of Action and Molecular Targets.
    Fontana F; Raimondi M; Marzagalli M; Di Domizio A; Limonta P
    Cells; 2020 Feb; 9(2):. PubMed ID: 32085497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.